Preeclampsia Severity and Its Impact on Neonatal and Parturient Outcomes: A Retrospective Study
International Journal of Pharmaceutical Quality Assurance · 28.02.2026 · 17 (2)
DOI: 10.25258/ijpqa.17.2.32 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 28.02.2026. Verfasst von Vineeta Singh und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Preeclampsia (PE) is a multisystem pregnancy disorder associated with significant maternal and neonatal morbidity and mortality. Disease severity influences peripartum outcomes, yet data from ‘ tertiary care centers remain limited.
Aim
To evaluate the impact of preeclampsia severity on maternal and neonatal outcomes in a tertiary care setting. Methodology: A retrospective observational study was conducted at Department of obstetrics and gynecology, SNMMCH, Dhanbad, analyzing records of 82 women diagnosed with PE over one year. Patients were categorized as severe (n=34) or non-severe (n=48) based on clinical and laboratory criteria. Maternal outcomes included mode of delivery, ICU admission, postpartum blood pressure management, and hospital stay. Neonatal outcomes included gestational age, birth weight, Apgar scores, NICU admission, and complications. Statistical analysis used t-tests, Chi-square, and Fisher’s exact tests, with p
Zitieren
APA
Singh, V., Kumar, A., Tubid, R., & Sinha, V. P. (2026). Preeclampsia Severity and Its Impact on Neonatal and Parturient Outcomes: A Retrospective Study. International Journal of Pharmaceutical Quality Assurance, 17(2). https://doi.org/10.25258/ijpqa.17.2.32
Vancouver
Singh V, Kumar A, Tubid R, Sinha VP. Preeclampsia Severity and Its Impact on Neonatal and Parturient Outcomes: A Retrospective Study. International Journal of Pharmaceutical Quality Assurance. 2026;17(2). doi:10.25258/ijpqa.17.2.32
BibTeX
@article{Singh2026,
author = {Singh, Vineeta and Kumar, Amit and Tubid, Rajluxmi and Sinha, Vijay Pratap},
title = {Preeclampsia Severity and Its Impact on Neonatal and Parturient Outcomes: A Retrospective Study},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {2},
doi = {10.25258/ijpqa.17.2.32}
}
EUVIMED